BIO-key Q2 FY26 net loss narrows to $0.57 million; revenue rises 13% to $1.92 million vs Q2 FY25
BKYI•Segment revenue and cash position
Service revenue fell 28% to $231,005 on lower maintenance and support renewals, while hardware revenue dropped 19% to $459,641.
Cash and cash equivalents totaled $1.38 million at June 30, 2026; net cash used in operations was $1.2 million for six months.
Q2 revenue and profitability improve
BIO-key reported second-quarter fiscal 2026 revenue up 13% to $1.92 million, driven by license revenue up 53% to $1.23 million.
Net loss narrowed to $575,000 from a year earlier, while operating loss improved to $533,000.
Gross profit margin widened to 87% from 73% on lower total cost of goods sold, which fell 47% to $245,951.
